H Lundbeck A/S is a Danish biotech company that is globally recognized for its innovative research and development of drugs for the treatment of neurological and psychiatric disorders. Lundbeck has a strong focus on sustainability and has been actively working towards decarbonisation and the adoption of renewable energy sources.

In 2020, Lundbeck announced its commitment to achieving carbon neutrality by 2040. To achieve this goal, the company has set a target of reducing its carbon emissions by 70% by 2030. Lundbeck has also committed to sourcing 100% renewable electricity for its operations by 2025. The company is actively exploring various renewable energy options, including wind, solar, and hydroelectric power.

To accelerate its decarbonisation efforts, Lundbeck has implemented several energy efficiency measures across its operations. The company has invested in energy-efficient lighting, heating, and cooling systems, and has also implemented a comprehensive energy management system to monitor and optimize its energy consumption.

Lundbeck has also adopted corporate power purchase agreements (PPAs) to support its transition to renewable energy. In 2020, the company signed a PPA with a wind farm in Norway, which will supply 50% of Lundbeck's electricity needs in Denmark. The PPA will enable Lundbeck to reduce its carbon emissions by approximately 12,000 tonnes per year.

In addition to its PPA, Lundbeck has also invested in on-site renewable energy generation. The company has installed solar panels on the roof of its headquarters in Copenhagen, which will generate approximately 200,000 kWh of renewable electricity per year. Lundbeck is also exploring the potential for on-site wind and hydroelectric power generation at its manufacturing facilities.

Lundbeck's commitment to sustainability extends beyond its energy and carbon reduction efforts. The company has implemented a comprehensive sustainability strategy that covers areas such as responsible sourcing, waste reduction, and employee well-being. Lundbeck has also established a sustainability governance structure, which includes a dedicated sustainability committee and regular reporting on sustainability performance.

Lundbeck's sustainability efforts have been recognized by several external organizations. In 2020, the company was included in the Dow Jones Sustainability Index (DJSI) for the sixth consecutive year. The DJSI is a global benchmark for corporate sustainability performance, and Lundbeck's inclusion reflects its strong sustainability performance across a range of environmental, social, and governance (ESG) criteria.

In conclusion, H Lundbeck A/S is a Danish biotech company that is committed to sustainability and decarbonisation. The company has set ambitious targets to reduce its carbon emissions and transition to renewable energy sources, and is actively exploring various renewable energy options. Lundbeck's sustainability efforts extend beyond its energy and carbon reduction efforts and cover areas such as responsible sourcing, waste reduction, and employee well-being. The company's strong sustainability performance has been recognized by several external organizations, including its inclusion in the Dow Jones Sustainability Index.